De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and T (Q33443385)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and T |
scientific article |
Statements
1 reference
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and T (English)
1 reference
Bahriye Aktas
1 reference
Oleg Gluz
1 reference
Matthias Christgen
1 reference
Ronald Ernest Kates
1 reference
Michael Braun
1 reference
Sherko Küemmel
1 reference
Claudia Schumacher
1 reference
Jochem Potenberg
1 reference
Stefan Kraemer
1 reference
Anke Kleine-Tebbe
1 reference
Doris Augustin
1 reference
Helmut Forstbauer
1 reference
Joke Tio
1 reference
Raquel von Schumann
1 reference
Cornelia Liedtke
1 reference
Eva-Maria Grischke
1 reference
Johannes Schumacher
1 reference
Rachel Wuerstlein
1 reference
Hans Heinrich Kreipe
1 reference
Ulrike Anneliese Nitz
1 reference
6 July 2017
1 reference
1 reference
JCO2016719815
1 reference
Identifiers
1 reference
1 reference